TAMPELLINI, MARCO
Dettaglio
TAMPELLINI, MARCO
ONCOLOGIA
Pubblicazioni
Risultati 1 - 20 di 117 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | A case of long-term survival after repeated response to oxaliplatin-based chemotherapy and repeated thermoablation of liver metastases from colorectal cancer. Should we introduce the concept of oxaliplatin-resistant tumors? | 2013 | Ottone A; Bellini E; Ferrero A; Baratelli C; Taberna E; Bitossi R; Brizzi MP; Tampellini M |
2 | Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma | 2009 | Brizzi MP; Sculli CM; Ragni F; Porpiglia F; Tampellini M; Gorzegno G; Priola AM; Dogliotti L; Berruti A. |
3 | Acute and fatal thrombocytopenic thrombotic purpura after a single dose of pemetrexed | 2014 | Irene Alabiso;Chiara Baratelli;Maria Pia Brizzi;Raffaella Bitossi;Azzurra Ottone;Marco Tampellini |
4 | Aggiornamenti in Cronochemioterapia | 2004 | Dogliotti L; Tampellini M; Angeli A |
5 | Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions | 2016 | Tampellini, Marco; Benedetto, Simone; Rubatto, Elena; Baratelli, Chiara; DI Scipio, Federica; Pirro, Elisa; Brizzi, Maria Pia; Sonetto, Cristina; DI Maio, Massimo; Berta, Giovanni Nicolao; Scagliotti, Giorgio Vittorio |
6 | Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome | 2008 | A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti |
7 | Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy | 2016 | Tampellini, Marco; Gned, Dario; Baratelli, Chiara; Brizzi, Maria Pia; Ottone, Azzurra; Alabiso, Irene; Bertaggia, Chiara; Di Maio, Massimo; Scagliotti, Giorgio Vittorio; Veltri, Andrea |
8 | Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. | 2008 | Generali D; Dovio A; Tampellini M; Tucci M; Tedoldi S; Torta M; Bonardi S; Allevi G; Aguggini S; Milani M; Harris AL; Bottini A; Dogliotti L; Angeli A; Berruti A. |
9 | Chirurgia delle metastasi polmonari da carcinoma colo-rettale: una serie di 171 pazienti. | 2014 | Luca Errico; Elena Lisi; Elena Asteggiano; Matteo Gagliasso; Nicola Liberato; Corrado Novello; Marco Tampellini; Francesco Ardissone |
10 | Chronomodulated delivery schedule of Oxaliplatin (OHP), 5-Fluorouracil and Folinic Acid (FFL4/10) allows to increase significantly dose intensity rate of OHP based schedule: 2 years experience in gastrointestinal cancers | 2004 | Masseroni S; Pirovano M; Nasisi A; Biffi A; Romanelli A; Sestini S; Valsecchi R; Martignoni G; Tabiadon D; Tampellini M |
11 | Circadian changes in mitoxantrone toxicity in mice: relationship with plasma pharmacokinetics. | 1994 | LÉVI F ;TAMPELLINI M ;METZGER G ;BIZI E ;LEMAIGRE G ;HALLEK M |
12 | Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer | 2009 | Innominato PF; Focan C; Gorlia T; Moreau T; Garufi C; Waterhouse J; Giacchetti S; Coudert B; Iacobelli S; Genet D; Tampellini M; Chollet P; Lentz MA; Mormont MC; Lévi F; Bjarnason GA |
13 | The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. | 2006 | A Dovio; D Generali; A Berruti; M Tampellini; S Tedoldi; S Bonardi; M Tucci; G Allevi; S Aguggini; M Milani; A Bottini; L Dogliotti; A Angeli |
14 | Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects | 2005 | D. G. Generali; S. Tedoldi; M. Tampellini; A. Berruti; M. Torta; S. Bonardi; A. Bottini; M. Tucci; M. Milani; A. Angeli; L. Dogliotti |
15 | CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS | 2004 | Daniele Generali; Sara Tedoldi; Alberto Bottini; Alfredo Berruti; Marco Tampellini; Marcello Tucci; Giovanni Allevi; Mirella Torta; Simone Bonardi; Manuela Milani; Sergio Aguggini; Alberto Angeli; Luigi Dogliotti |
16 | Circadian rhythm of breakthrough cancer pain. | 2011 | A. Saini; M. Tucci; K. Bouraouia; P. Ghio; M. Tampellini; P. M. Furlan; L. Ostacoli; L. Dogliotti; A. Berruti |
17 | The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients | 2019 | Campagna, Sara; Sperlinga, Riccardo; Milo, Antonella; Sannuto, Simona; Acquafredda, Fabio; Saini, Andrea; Gonella, Silvia; Berruti, Alfredo; Scagliotti, Giorgio Vittorio; Tampellini, Marco |
18 | Circadian variation of breakthrough pain in cancer patients. | 2013 | Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A |
19 | Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy | 2015 | Tampellini, M; Polverari, R.S.; Ottone, A.; Alabiso, I.; Baratelli, C.; Bitossi, R.; Brizzi, M.P.; Leone, F.; Forti, L.; Bertona, E.; Racca, P.; Mecca, C.; Alabiso, O.; Aglietta, M.; Berruti, A.; Scagliotti, G.V. |
20 | Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma | 2017 | Cusato, Jessica; DE FRANCIA, Silvia; Allegra, Sarah; Carrella, Simona; Pirro, Elisa; Piccione, Francesca Maria; De Martino, Francesca; Ferrero, Anna; Daffara, Fulvia Claudia; Terzolo, Massimo; Berruti, Alfredo; DI CARLO, Francesco; Tampellini, Marco; D'Avolio, Antonio |